Skip to content

News

FILTER

AllPress ReleasesScientific Resources
December 22, 2021 |

Ingenew Pharma Announces the Completion of the Hesperidin Virtual Clinical Trial in COVID-19 Subjects

Proof-of-concept of a virtual Phase 2 double-blind placebo-controlled clinical trial Hesperidin 1g daily reduced COVID-19 symptoms compared to placebo Montreal, December 22, 2021. Ingenew Pharma announces it has completed a
February 16, 2021 |

New Clinical Trial on Hesperidin

A natural product to fight symptoms related to COVID-19 The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to
September 3, 2020 |

Valeo Pharma Receives Hesperco(TM) Natural Product License Approval From Health Canada

HespercoTM capsules for immune system support to be commercially available by end of September 2020 HespercoTM pre-sales now available at online store   MONTREAL, QUEBEC , September 3, 2020 –
July 13, 2020 |

Ortho Regenerative Technologies Enters Into Licensing Agreement To Expand The Scope Of Its Technological Platform Applications

Montreal, QC, May 20, 2020 – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company”), an emerging orthobiologics company, today announced that it has entered into a strategic